Energy crisis / European pharmaceutical companies may stop the production of some drugs
European drugmakers have warned they may stop making some drugs because of rising electricity costs.
The generic drug industry lobby group Medicines for Europe sent an open letter to the energy and health ministers of the European Union member states this week.
The letter said that electricity prices have increased 10-fold for some drug factories in Europe and raw material costs have increased by 50 percent to 160 percent.
They demanded that the pharmaceutical industry be excluded from EU measures to reduce electricity consumption and that the drug sector be included in state aid designed to support the economy.